Canopy Growth Corporation is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Luc Mongeau, with a market cap of $460.9M.
Common questions about Canopy Growth Corporation
Canopy Growth Corporation is scheduled to report earnings for Q4 2026 on May 29, 2026. Analysts estimate revenue of $53.3M.
Canopy Growth Corporation has approximately 1,029 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.